Register Login

Rivaroxaban Update

The European Medicines Agency Committee for Medicinal Products for Human Use now recommends rivaroxaban for prevention of stroke in atrial fibrillation and for treatment of venous thromboembolism, as reported by The Heart.org.

Comments (0)
Posts

No comments here.

Leave a Reply